Tacrolimus ameliorates tubulointerstitial inflammation in diabetic nephropathy via inhibiting the NFATc1/TRPC6 pathway. Issue 17 (11th August 2020)
- Record Type:
- Journal Article
- Title:
- Tacrolimus ameliorates tubulointerstitial inflammation in diabetic nephropathy via inhibiting the NFATc1/TRPC6 pathway. Issue 17 (11th August 2020)
- Main Title:
- Tacrolimus ameliorates tubulointerstitial inflammation in diabetic nephropathy via inhibiting the NFATc1/TRPC6 pathway
- Authors:
- Zhang, Shumin
Wang, Huafen
Liu, Yifei
Yang, Wenxia
Liu, Jialu
Han, Yuzhang
Liu, Yu
Liu, Fuyou
Sun, Lin
Xiao, Li - Abstract:
- Abstract: Tubulointerstitial inflammation is crucial for the progression of diabetic nephropathy (DN), and tubular cells act as a driving force in the inflammatory cascade. Emerging data suggested that tacrolimus (TAC) ameliorates podocyte injury and macrophage infiltration in streptozotocin (STZ) mice. However, the effect of TAC on tubulointerstitial inflammation remains unknown. We found that albuminuria and tubulointerstitial damage improved in db/db mice treated with TAC. Macrophage infiltration and expression of IL‐6, TNF‐α, fibronectin, collagen 1 and cleaved caspase 3 were inhibited as well. In addition, the expression of nuclear factor of activated T cell 1 (NFATc1) and transient receptor potential channel 6 (TRPC6) was up‐regulated in the kidneys of DN patients and correlated with tubular injury and inflammation. The expression of NFATc1 and TRPC6 also increased in the kidneys of db/db mice and HK‐2 cells with high glucose (HG), while TAC inhibited these effects. HG‐induced inflammatory markers and apoptosis were reversed by TAC and NFATc1 siRNA in HK‐2 cells, which was abolished by TRPC6 plasmid. Furthermore, HG‐induced TRPC6 expression was inhibited by NFATc1 siRNA, while NFATc1 nuclear translocation was inhibited by TAC, but was restored by TRPC6 plasmid in HK‐2 cells under HG conditions. These findings suggest that TAC ameliorates tubulointerstitial inflammation in DN through NFATc1/TRPC6 feedback loop.
- Is Part Of:
- Journal of cellular and molecular medicine. Volume 24:Issue 17(2020)
- Journal:
- Journal of cellular and molecular medicine
- Issue:
- Volume 24:Issue 17(2020)
- Issue Display:
- Volume 24, Issue 17 (2020)
- Year:
- 2020
- Volume:
- 24
- Issue:
- 17
- Issue Sort Value:
- 2020-0024-0017-0000
- Page Start:
- 9810
- Page End:
- 9824
- Publication Date:
- 2020-08-11
- Subjects:
- diabetic nephropathy -- inflammation -- NFATc1 -- tacrolimus -- TRPC6 -- tubular cell
Cytology
Medicine
Molecular Biology
Cytologie -- Périodiques
Médecine -- Périodiques
Biologie moléculaire -- Périodiques
Cytology -- Periodicals
Medicine -- Periodicals
Molecular biology -- Periodicals
611.01805 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1582-4934 ↗
http://www.blackwell-synergy.com/loi/jcmm ↗
http://www.usc.edu/hsc/nml/e-resources/info/joucelmm.html ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/jcmm.15562 ↗
- Languages:
- English
- ISSNs:
- 1582-1838
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4955.005000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23855.xml